相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。Intragenic Rearrangement and Altered RNA Splicing of the Androgen Receptor in a Cell-Based Model of Prostate Cancer Progression
Yingming Li et al.
CANCER RESEARCH (2011)
Abiraterone and Increased Survival in Metastatic Prostate Cancer
Johann S. De Bono et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
Identification of Novel Truncated Androgen Receptor (AR) Mutants Including Unreported Pre-mRNA Splicing Variants in the 22Rv1 Hormone-Refractory Prostate Cancer (PCa) Cell Line
Gemma Marcias et al.
HUMAN MUTATION (2010)
ERK Regulates Calpain 2-induced Androgen Receptor Proteolysis in CWR22 Relapsed Prostate Tumor Cell Lines
Honglin Chen et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2010)
Castration resistance in human prostate cancer is conferred by a frequently occurring androgen receptor splice variant
Shihua Sun et al.
JOURNAL OF CLINICAL INVESTIGATION (2010)
Antitumour activity of MDV3100 in castration-resistant prostate cancer: a phase 1-2 study
Howard I. Scher et al.
LANCET (2010)
Constitutively active androgen receptor splice variants expressed in castration-resistant prostate cancer require full-length androgen receptor
Philip A. Watson et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
Antitumor Activity with CYP17 Blockade Indicates That Castration-Resistant Prostate Cancer Frequently Remains Hormone Driven
Gerhardt Attard et al.
CANCER RESEARCH (2009)
A Novel Androgen Receptor Splice Variant Is Up-regulated during Prostate Cancer Progression and Promotes Androgen Depletion-Resistant Growth
Zhiyong Guo et al.
CANCER RESEARCH (2009)
Ligand-Independent Androgen Receptor Variants Derived from Splicing of Cryptic Exons Signify Hormone-Refractory Prostate Cancer
Rong Hu et al.
CANCER RESEARCH (2009)
Starving the Addiction: New Opportunities for Durable Suppression of AR Signaling in Prostate Cancer
Karen E. Knudsen et al.
CLINICAL CANCER RESEARCH (2009)
Anti-androgens and androgen-depleting therapies in prostate cancer: new agents for an established target
Yu Chen et al.
LANCET ONCOLOGY (2009)
Development of a Second-Generation Antiandrogen for Treatment of Advanced Prostate Cancer
Chris Tran et al.
SCIENCE (2009)
Splicing of a novel androgen receptor exon generates a constitutively active androgen receptor that mediates prostate cancer therapy resistance
Scott M. Dehm et al.
CANCER RESEARCH (2008)
Stimulation of N-terminal truncated isoform of androgen receptor stabilizes human ether-a-go-go-related gene-encoded potassium channel protein via activation of extracellular signal regulated kinase 1/2
Zhi-Yuan Wu et al.
ENDOCRINOLOGY (2008)
Structural basis for the nuclear import of the human androgen receptor
Mark L. Cutress et al.
JOURNAL OF CELL SCIENCE (2008)
The intersection of steroid receptors with molecular chaperones: Observations and questions
David F. Smith et al.
MOLECULAR ENDOCRINOLOGY (2008)
Androgen receptor (AR) coregulators: A diversity of functions converging on and regulating the AR transcriptional complex
Hannelore V. Heemers et al.
ENDOCRINE REVIEWS (2007)
Selective role of an NH2-Terminal WxxLF motif for aberrant androgen receptor activation in androgen depletion-independent prostate cancer cells
Scott M. Dehm et al.
CANCER RESEARCH (2007)
Evidence for calpain-mediated androgen receptor cleavage as a mechanism for androgen independence
Stephen J. Libertini et al.
CANCER RESEARCH (2007)
A splicing variant of the androgen receptor detected in a metastatic prostate cancer exhibits exclusively cytoplasmic actions
Monika Jagla et al.
ENDOCRINOLOGY (2007)
Molecular regulation of androgen action in prostate cancer
Scott M. Dehm et al.
JOURNAL OF CELLULAR BIOCHEMISTRY (2006)
Androgen axis in prostate cancer
Zoran Culig et al.
JOURNAL OF CELLULAR BIOCHEMISTRY (2006)
Androgen receptor action in hormone-dependent and recurrent prostate cancer
Irina U. Agoulnik et al.
JOURNAL OF CELLULAR BIOCHEMISTRY (2006)
Interplay between two hormone-independent activation domains in the androgen receptor
L Callewaert et al.
CANCER RESEARCH (2006)
Context-dependent hormone-refractory progression revealed through characterization of a novel murine prostate cancer cell line
PA Watson et al.
CANCER RESEARCH (2005)
The molecular mechanisms of coactivator utilization in ligand-dependent transactivation by the androgen receptor
E Estébanez-Perpiña et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
Androgen receptor function is modulated by the tissue-specific AR45 variant
I Ahrens-Fath et al.
FEBS JOURNAL (2005)
Effect of GGC (glycine) repeat length polymorphism in the human androgen receptor on androgen action
DC Ding et al.
PROSTATE (2005)
Structural basis of androgen receptor binding to selective androgen response elements
PL Shaffer et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2004)
Androgen receptor in prostate cancer
CA Heinlein et al.
ENDOCRINE REVIEWS (2004)
Recognition and accommodation at the androgen receptor coactivator binding interface
E Hur et al.
PLOS BIOLOGY (2004)
Structural basis for androgen receptor interdomain and coactivator interactions suggests a transition in nuclear receptor activation function dominance
B He et al.
MOLECULAR CELL (2004)
The androgen receptor gene mutations database (ARDB): 2004 update
B Gottlieb et al.
HUMAN MUTATION (2004)
Effect of a short CAG (glutamine) repeat on human androgen receptor functin
DC Ding et al.
PROSTATE (2004)
The androgen receptor CAG repeat: a modifier of carcinogenesis?
P Ferro et al.
MOLECULAR AND CELLULAR ENDOCRINOLOGY (2002)
Molecular basis of androgen insensitivity
AO Brinkmann
MOLECULAR AND CELLULAR ENDOCRINOLOGY (2001)
A unique exonic splicing mutation in the human androgen receptor gene indicates a physiologic relevance of regular androgen receptor transcript variants
OJC Hellwinkel et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2001)
Crystallographic structures of the ligand-binding domains of the androgen receptor and its T877A mutant complexed with the natural agonist dihydrotestosterone
JS Sack et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2001)
Structural evidence for ligand specificity in the binding domain of the human androgen receptor -: Implications for pathogenic gene mutations
PM Matias et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2000)
Novel point mutation in the splice donor site of exon-intron junction 6 of the androgen receptor gene in a patient with partial androgen insensitivity syndrome
I Sammarco et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2000)